Glanzmann's thrombasthenia secondary prevention
|
Glanzmann's thrombasthenia |
|
Differentiating Glanzmann's thrombasthenia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glanzmann's thrombasthenia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Glanzmann's thrombasthenia secondary prevention |
|
Risk calculators and risk factors for Glanzmann's thrombasthenia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Glanzmann’s thrombasthenia patients need regular dental visits and must maintain good oral hygiene because the recurrence of gingival bleeding is more in them. These patient should avoid contact sports. Women with GT, because of menorrhagia, should be monitored regularly for iron deficiency anemia and if needed, should receive iron supplements.
85 % of patients with Glanzmann’s thrombasthenia require at least once in their lifetime blood transfusion, so they should be immunized against hepatitis B.
GT patients should not use non-steroidal anti-inflammatory drugs(NSAID) and aspirin.
GT Patients require HLA typing at the time of diagnosis, and should be monitored for HLA and anti-platelet antibodies. Patients should be educated,how to control bleeding from a minor wound or epistaxis by means of pressure or taking an oral anti-fibrinolytic drug ,and they should approach a medical professional in the case of uncontrolled bleeding.
Secondary Prevention
Glanzmann’s thrombasthenia patients need regular dental visits and must maintain good oral hygiene because the recurrence of gingival bleeding is more in them.
These patient should avoid contact sports.
Women with GT, because of menorrhagia, should be monitored regularly for iron deficiency anemia and if needed, should receive iron supplements.
85 % of patients with Glanzmann’s thrombasthenia require at least once in their lifetime blood transfusion, so they should be immunized against hepatitis B.
GT patients should not use non-steroidal anti-inflammatory drugs(NSAID) and aspirin.
GT Patients require HLA typing at the time of diagnosis, and should be monitored for HLA and anti-platelet antibodies.
Patients should be educated,how to control bleeding from a minor wound or epistaxis by means of pressure or taking an oral anti-fibrinolytic drug ,and they should approach a medical professional in the case of uncontrolled bleeding.